Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib vs Chemotherapy in Non-adipocyte Soft Tissue Sarcoma (PazoQoL)
NCT03735758Phase 4Terminated
- Sponsor
- GWT-TUD
- Start
- Nov 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pazopanib in soft tissue sarcoma (STS), sponsored by GWT-TUD. Started Nov 2018; status: terminated.
02
Drugs
pazopanib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT03735758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03735758.